Skip to main content
Top
Published in: Journal of General Internal Medicine 9/2011

01-09-2011 | Editorials

Safe Opioid Prescribing: A Long Way to Go

Authors: Jane M. Liebschutz, MD MPH, Daniel P. Alford, MD MPH

Published in: Journal of General Internal Medicine | Issue 9/2011

Login to get access

Excerpt

Chronic pain is one of the most common reasons why patients visit a physician; yet, physicians are poorly trained to manage it. Despite centuries-long therapeutic use of opioids for pain, they fell out of favor for most of the 20th century in the US. However, in the 1980s, medical literature began to support the practice of prescribing opioids for chronic non-cancer pain.1 Opioid prescribing then escalated over the past two decades,2 despite lack of strong evidence supporting this practice.3 Although it started as an antidote to under-treatment of pain, increased opioid prescribing has paralleled increases in opioid misuse including overdoses, diversion and addiction.4,5. Over the last decade, the medical and public health communities have begun to address this problem by cautioning that all patients prescribed opioids carry some degree of risk for opioid misuse. Recent clinical guidelines based on expert consensus now endorse universal assessment for opioid misuse risk and monitoring for subsequent potential harm.68 The guidelines suggest that patients at “high risk” for misuse should be identified through individual patient risk factors, such as an existing diagnosis of substance use disorder (SUD), mental health problems, history of legal problems and younger age. Treating chronic pain with opioids should include monitoring for harm including urine drug testing to detect any illicit substance use and whether the prescribed opioid is being taken , frequent prescriber visits, pill counts to evaluate adherence with opioid dosing and to minimize diversion, use of state prescription drug monitoring program data, when available, and addressing aberrant opioid taking behaviors9,10 such as patients requests for early refills. More intensive monitoring is recommended for those with more risk factors. When necessary, physicians should also refer patients to adjunctive mental health or addiction treatment specialists for co-management, when such services are available. …
Literature
1.
go back to reference Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases. Pain. 1986;25(2):171–86.PubMedCrossRef Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases. Pain. 1986;25(2):171–86.PubMedCrossRef
2.
go back to reference Olsen Y, Daumit GL, Ford DE. Opioid prescriptions by U.S. primary care physicians from 1992 to 2001. J Pain. 2006;7(4):225–35.PubMedCrossRef Olsen Y, Daumit GL, Ford DE. Opioid prescriptions by U.S. primary care physicians from 1992 to 2001. J Pain. 2006;7(4):225–35.PubMedCrossRef
3.
go back to reference Martell BA, O'Connor PG, Kerns RD, et al. Systematic review: Opioid treatment for chronic back pain: Prevalence, efficacy, and association with addiction. Ann Intern Med. 2007;146(2):116–27.PubMed Martell BA, O'Connor PG, Kerns RD, et al. Systematic review: Opioid treatment for chronic back pain: Prevalence, efficacy, and association with addiction. Ann Intern Med. 2007;146(2):116–27.PubMed
4.
go back to reference Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the united states. Pharmacoepidemiol Drug Saf. 2006;15(9):618–27.PubMedCrossRef Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the united states. Pharmacoepidemiol Drug Saf. 2006;15(9):618–27.PubMedCrossRef
5.
go back to reference Paulozzi LJ, Xi Y. Recent changes in drug poisoning mortality in the united states by urban-rural status and by drug type. Pharmacoepidemiol Drug Saf. 2008;17(10):997–1005.PubMedCrossRef Paulozzi LJ, Xi Y. Recent changes in drug poisoning mortality in the united states by urban-rural status and by drug type. Pharmacoepidemiol Drug Saf. 2008;17(10):997–1005.PubMedCrossRef
7.
go back to reference Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: A rational approach to the treatment of chronic pain. Pain Med. 2005;6(2):107–12.PubMedCrossRef Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: A rational approach to the treatment of chronic pain. Pain Med. 2005;6(2):107–12.PubMedCrossRef
8.
go back to reference Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113–30.PubMedCrossRef Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113–30.PubMedCrossRef
9.
go back to reference Passik SD, Kirsh KL. Assessing aberrant drug-taking behaviors in the patient with chronic pain. Current Pain & Headache Reports. 2004;8(4):289–94.CrossRef Passik SD, Kirsh KL. Assessing aberrant drug-taking behaviors in the patient with chronic pain. Current Pain & Headache Reports. 2004;8(4):289–94.CrossRef
10.
go back to reference Passik SD, Messina J, Golsorkhi A, Xie F. Aberrant drug-related behavior observed during clinical studies involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet for breakthrough pain. J Pain Symptom Manage. 2011;41(1):116–25. Passik SD, Messina J, Golsorkhi A, Xie F. Aberrant drug-related behavior observed during clinical studies involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet for breakthrough pain. J Pain Symptom Manage. 2011;41(1):116–25.
11.
go back to reference Starrels JL, Becker WC, Weiner MG, Li X, Heo M, Turner BJ. Low use of opioid risk reduction strategies in primary care even for high risk patients with chronic pain. Journal of General Internal Medicine. 2011: doi:10.1007/s11606-011-1648-2. Starrels JL, Becker WC, Weiner MG, Li X, Heo M, Turner BJ. Low use of opioid risk reduction strategies in primary care even for high risk patients with chronic pain. Journal of General Internal Medicine. 2011: doi:10.​1007/​s11606-011-1648-2.
12.
go back to reference Morasco BJ, Duckart JP, Dobschz SK. Adherence to clinical guidelines for opioid therapy for chronic pain in patients with substance use disorder. Journal of General Internal Medicine. 2011: doi:10.1007/s11606-011-1734-5. Morasco BJ, Duckart JP, Dobschz SK. Adherence to clinical guidelines for opioid therapy for chronic pain in patients with substance use disorder. Journal of General Internal Medicine. 2011: doi:10.​1007/​s11606-011-1734-5.
13.
go back to reference Yanni LM, McKinney-Ketchum JL, Harrington SBH, C, et al. Preparation, confidence and attitudes about chronic noncancer pain in graduate medical education. J Grad Med Ed. 2010:260–8. Yanni LM, McKinney-Ketchum JL, Harrington SBH, C, et al. Preparation, confidence and attitudes about chronic noncancer pain in graduate medical education. J Grad Med Ed. 2010:260–8.
14.
go back to reference O'Connor PG, Nyquist JG, McLellan AT. Integrating addiction medicine into graduate medical education in primary care: The time has come. Ann Intern Med. 2011;154(1):56–9.PubMed O'Connor PG, Nyquist JG, McLellan AT. Integrating addiction medicine into graduate medical education in primary care: The time has come. Ann Intern Med. 2011;154(1):56–9.PubMed
16.
17.
go back to reference Starrels JL, Becker WC, Alford DP, Kapoor A, Williams AR, Turner BJ. Systematic review: Treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Ann Intern Med. 2010;152(11):712–20.PubMed Starrels JL, Becker WC, Alford DP, Kapoor A, Williams AR, Turner BJ. Systematic review: Treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Ann Intern Med. 2010;152(11):712–20.PubMed
18.
go back to reference Mularski RA, White-Chu F, Overbay D, Miller L, Asch SM, Ganzini L. Measuring pain as the 5th vital sign does not improve quality of pain management. J Gen Intern Med. 2006;21(6):607–12.PubMedCrossRef Mularski RA, White-Chu F, Overbay D, Miller L, Asch SM, Ganzini L. Measuring pain as the 5th vital sign does not improve quality of pain management. J Gen Intern Med. 2006;21(6):607–12.PubMedCrossRef
19.
go back to reference Heit HA, Gourlay DL. Urine drug testing in pain medicine. J Pain Symptom Manage. 2004;27(3):260–7.PubMedCrossRef Heit HA, Gourlay DL. Urine drug testing in pain medicine. J Pain Symptom Manage. 2004;27(3):260–7.PubMedCrossRef
20.
go back to reference Bhamb B, Brown D, Hariharan J, Anderson J, Balousek S, Fleming MF. Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain. Curr Med Res Opin. 2006;22(9):1859–65.PubMedCrossRef Bhamb B, Brown D, Hariharan J, Anderson J, Balousek S, Fleming MF. Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain. Curr Med Res Opin. 2006;22(9):1859–65.PubMedCrossRef
21.
go back to reference Scanlon MN, Chugh U. Exploring physicians' comfort level with opioids for chronic noncancer pain. Pain Res Manag. 2004;9(4):195–201.PubMed Scanlon MN, Chugh U. Exploring physicians' comfort level with opioids for chronic noncancer pain. Pain Res Manag. 2004;9(4):195–201.PubMed
22.
go back to reference Curtis LH, Stoddard J, Radeva JI, et al. Geographic variation in the prescription of schedule II opioid analgesics among outpatients in the united states. Health Serv Res. 2006;41(3 Pt 1):837–55.PubMedCrossRef Curtis LH, Stoddard J, Radeva JI, et al. Geographic variation in the prescription of schedule II opioid analgesics among outpatients in the united states. Health Serv Res. 2006;41(3 Pt 1):837–55.PubMedCrossRef
23.
go back to reference Webster BS, Cifuentes M, Verma S, Pransky G. Geographic variation in opioid prescribing for acute, work-related, low back pain and associated factors: A multilevel analysis. Am J Ind Med. 2009;52(2):162–71.PubMedCrossRef Webster BS, Cifuentes M, Verma S, Pransky G. Geographic variation in opioid prescribing for acute, work-related, low back pain and associated factors: A multilevel analysis. Am J Ind Med. 2009;52(2):162–71.PubMedCrossRef
Metadata
Title
Safe Opioid Prescribing: A Long Way to Go
Authors
Jane M. Liebschutz, MD MPH
Daniel P. Alford, MD MPH
Publication date
01-09-2011
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 9/2011
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-011-1797-3

Other articles of this Issue 9/2011

Journal of General Internal Medicine 9/2011 Go to the issue

Innovation and Improvement: Improvement Happens

Improvement Happens: an Interview with Furman McDonald, MD MPH

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.